Safety, pharmacokinetics, and biologic activity of pateclizumab, a novel monoclonal antibody targeting lymphotoxin α: results of a phase I randomized, placebo-controlled trial (Q36084891)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety, pharmacokinetics, and biologic activity of pateclizumab, a novel monoclonal antibody targeting lymphotoxin α: results of a phase I randomized, placebo-controlled trial |
scientific article |
Statements
1 reference
Safety, pharmacokinetics, and biologic activity of pateclizumab, a novel monoclonal antibody targeting lymphotoxin α: results of a phase I randomized, placebo-controlled trial (English)
1 reference
Brinda Emu
1 reference
Diana Luca
1 reference
Carolyn Offutt
1 reference
Jane L Grogan
1 reference
Bernadette Rojkovich
1 reference
Marna B Williams
1 reference
Meina T Tang
1 reference
Jim Xiao
1 reference
June H Lee
1 reference
John C Davis
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference